Table 2.
Data stratified by Black versus White race.
| All Patients | White (N = 219) | Black (N = 70) | p-value |
|---|---|---|---|
|
| |||
| Patient Characteristics | |||
| Age at diagnosis (years) | 65 (52–73) | 58 (51–66) | 0.01 |
| Female | 104 (47.5 %) | 49 (70.0 %) | 0.01 |
| BMI, median | 28.1 (24.6–32.3) | 29.3 (25.8–35.2) | 0.06 |
| Prior history of unrelated cancer | 46 (21.0 %) | 6 (8.6 %) | 0.02 |
| Tumor Characteristics | |||
| Tumor size (cm) | 8.5 (4.5–14.5) | 9.5 (6.3–15.4) | 0.20 |
| Mitoses | 84 (38.3) | 25 (35.7) | 0.93 |
| Necrosis | 78 (35.6 %) | 34 (48.6 %) | 0.13 |
| Hemorrhage | 42 (19.2 %) | 17 (24.3 %) | 0.14 |
| Stage at Diagnosis | 0.82 | ||
| Non-metastatic | 181 (82.6 %) | 57 (81.4 %) | |
| Metastatic | 38 (17.4 %) | 13 (18.6 %) | |
| Treatment, n (%) | |||
| Neoadjuvant chemotherapy | 14 (6.4 %) | 8 (11.4 %) | 0.38 |
| Surgery | 191 (87.2 %) | 57 (81.4 %) | 0.42 |
| Radiation | 91 (41.6 %) | 27 (38.6 %) | 0.66 |
| Outcomes | |||
| Follow-up time (days) | 474 (247–1075) | 322 (134–704) | 0.01 |
| Death | 77 (35.2 %) | 30 (42.9 %) | 0.25 |